Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

about

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

Item

http://www.wikidata.org/entity/Q35573997

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

@ast

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

@en

type

Item

label

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

@ast

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

@en

prefLabel

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

@ast

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

@en

P1476

Worsening of hyperglycemia due to atorvastatin in a renal transplant patient.

@en

P2093

Naomi Nacasch

http://www.w3.org/2001/XMLSchema#string

Ze'ev Korzets

http://www.w3.org/2001/XMLSchema#string

P2860

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?

Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells.

Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes.

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.

Patient survival after renal transplantation III: the effects of statins.

Diabetes mellitus after kidney transplantation in the United States.

Pitavastatin inhibits vascular smooth muscle cell proliferation by inactivating extracellular signal-regulated kinases 1/2.

P304

392-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1093/NDTPLUS/SFP058

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273376476

http://www.w3.org/2001/XMLSchema#string

P698

25949354

http://www.w3.org/2001/XMLSchema#string

P921

hyperglycemia

P932

4421381

http://www.w3.org/2001/XMLSchema#string